I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
The inHealth Precision Medicine Conference
Immunotherapy: Precision Medicine in Action The importance of keeping the promise and potential of immunotherapy alive
The first cancer immunotherapy was approved in 2011; today, there are more than 70 such drugs in the clinical pipeline. By 2020, the cancer treatment industry is expected to achieve $16.55 billion dollars in revenue. Read our policy brief to learn more about milestones in cancer immunotherapy.
What do precision medicine, Johns Hopkins inHealth and Darwin have in common? If you’re interested, please plan to attend our first ever inHealth Precision Medicine Conference on Tuesday, March 27 from 8am to 1pm in Turner Auditorium. You’ll learn about the new analytics, big data, and measurement platforms we’re building to transform medicine, as well as some highly creative approaches your colleagues have taken to further define individual diseases and conditions to both improve care and minimize cost.
March 27, 2018, Turner Auditorium
Goal: Framing the transformation of health care at Johns Hopkins
7:00 a.m. – 8:00 a.m. Breakfast and registration
8:00 a.m. – 8:30 a.m. Keynote Speaker – A. Rosen: Hopkins inHealth: Recognizing Wonder at Scale
Session I – Precision Medicine: Template for the future of Johns Hopkins Medicine
8:30 a.m. – 9:00 a.m. – Precision Medicine Analytics Platform: Dwight Raum
9:00 a.m. – 9:15 a.m. – APL's Health Mission: Collaborations with JHM: Alan Ravitz
9:15 a.m. – 9:30 a.m. – Applications of Data Science to Precision Medicine: Corban Rivera
9:30 a.m. – 9:45 a.m. – Transforming Data Delivery with the Precision Medicine Platform: Diana Gumas
9:45 a.m. – 10:00 a.m. – Released Tumor DNA as a Clinical Biomarker Ken Kinzler
10:00 a.m. – 10:15 a.m. – Imaging Neurodegeneration Using Retinal Optical Coherence Tomography Peter A. Calabresi
10:15 a.m. – 10:45 a.m. – Break
Session II – Creative subsetting: Voyages of the Hopkins “Beagle”
10:45 a.m. – 11:00 a.m. – H. Ballentine Carter: A prostate cancer subgroup: Individualizing care and informing health policy
11:00 a.m. – 11:15 a.m. – Peter Searson: Patient mobility and the importance of high information content data
11:15 a.m. – 11:30 a.m. – Joshua Betz: Optimizing Clinical Trial Designs for Evaluating Subgroup Effects
11:30 a.m. – 11:45 a.m. – Natalia Trayanova: Predictive Computational Modeling in Diagnosis and Treatment of Heart Rhythm Disorders
11:45 a.m. – 12:00 p.m. – David McConkey: Genomic subtypes in the clinical management of bladder cancer
12:00 p.m. – 1:00 p.m. – Roundtable on the Precision Medicine Path to Value
Moderator: Antony Rosen
Roundtable participants: Redonda Miller, Patty Brown, Stephanie Reel, Landon King, Robert Kasdin
1:00 p.m. – Lunch
Sign Up for Fundamentals
Stay up-to-date with the latest research findings from the Institute for Basic Biomedical Sciences.